Tattoo-Induced Cutaneous Lymphoid Hyperplasia: A Case Series and Review of the Literature
Dermatology Practical & Conceptual · 30.04.2026 · 16 (2) · 6251
DOI: 10.5826/dpc.1602a6251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.04.2026. Verfasst von Cesare Ariasi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Brescia, Brescia, Italy. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The increasing popularity of tattoos has been paralleled by a rise in tattoo-related skin reactions. Among these, tattoo-induced cutaneous lymphoid hyperplasia (CLH) remains a rare but increasingly recognized complication. Its pathogenesis and incidence are not yet fully understood, and diagnosis relies on histopathological confirmation via skin biopsy. Treatment approaches include topical or intralesional corticosteroids, surgical excision, and ablative CO₂ laser therapy in refractory cases.
Objectives
To analyze and describe the clinical and histopathological features of tattoo-induced CLH, including patient demographics, tattoo characteristics (e.g., location, ink color), latency periods, and lymphocyte predominance.
Methods
This study presents a case series of 15 patients with histologically-confirmed tattoo-induced CLH observed at dermatology departments in Brescia, Italy, and Gdańsk, Poland, between May 2017 and June 2023. These cases were integrated with a comprehensive literature review, resulting in a total of 58 patients analyzed. Data collected included patient demographics, tattoo location, latency period between tattooing and lesion onset, clinical features, ink color involved, lymphocyte predominance on histology, treatment modalities, and outcomes. The median patient age was 39 years, with an average latency of 33 months.
Results
Red ink was the most frequently implicated pigment. The predominant histopathological pattern was T-cell infiltration. Treatment responses varied. While topical and intralesional steroids showed inconsistent efficacy, surgical excision and ablative CO₂ laser treatments yielded the most favorable and sustained outcomes.
Conclusions
These findings underscore the importance of recognizing CLH as a delayed immune-mediated reaction, particularly to red pigments. Accurate diagnosis through biopsy is essential to distinguishing CLH from other tattoo-related dermatoses or cutaneous lymphomas, guiding appropriate management strategies.
Autor:innen und Institutionen
- Department of Dermatology, University of Brescia, Brescia, Italy.
- Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
- Clinic of Dermatology, Department of Medicine and Aging Sciences, University G. D'Annunzio, Chieti, Italy.
- Clinic of Dermatology, San Antonio Abate Hospital, Trapani, Italy.
Zitieren
APA
Ariasi, C., Rogowska, P., Damiani, C., Artelli, G. L., Galli, B., Vascellaro, A., Gualdi, G., Soglia, S., Venturini, M., Arisi, M., Licata, G., Szczerkowska-Dobosz, A., & Calzavara-Pinton, P. (2026). Tattoo-Induced Cutaneous Lymphoid Hyperplasia: A Case Series and Review of the Literature. Dermatology Practical & Conceptual, 16(2), 6251. https://doi.org/10.5826/dpc.1602a6251
Vancouver
Ariasi C, Rogowska P, Damiani C, Artelli GL, Galli B, Vascellaro A, et al. Tattoo-Induced Cutaneous Lymphoid Hyperplasia: A Case Series and Review of the Literature. Dermatology Practical & Conceptual. 2026;16(2):6251. doi:10.5826/dpc.1602a6251
BibTeX
@article{Ariasi2026,
author = {Ariasi, Cesare and Rogowska, Patrycja and Damiani, Caterina and Artelli, Grazia Linda and Galli, Benedetta and Vascellaro, Annalisa and Gualdi, Giulio and Soglia, Simone and Venturini, Marina and Arisi, Mariachiara and Licata, Gaetano and Szczerkowska-Dobosz, Aneta and Calzavara-Pinton, Piergiacomo},
title = {Tattoo-Induced Cutaneous Lymphoid Hyperplasia: A Case Series and Review of the Literature},
journal = {Dermatology Practical & Conceptual},
year = {2026},
volume = {16},
number = {2},
pages = {6251},
doi = {10.5826/dpc.1602a6251}
}
EUVIMED